
Seytri T 1000mg/125mg Injection
Marketer
Hauz Pharma Pvt Ltd
Salt Composition
Ceftriaxone (1000mg) + Tazobactum (125mg)
Overview Seytri T 1000mg/125mg Injection
Combiflox 1000mg/125mg Injection, a dual-action antibiotic, combats diverse bacterial infections by inhibiting microbial proliferation and halting infection spread. Administration must be overseen by a medical professional. Consistent adherence to the prescribed dosage schedule is crucial; completing the entire course is vital, even with symptom improvement, as premature cessation can compromise efficacy. Common side effects may include nausea, vomiting, diarrhea, and dyspepsia. Severe side effects warrant immediate medical consultation. Allergic reactions (rash, pruritus, edema, dyspnea) necessitate urgent medical attention. Prior to use, disclose all current medications to your physician. Pregnant or lactating individuals should seek medical advice. Alcohol consumption should be avoided due to potential additive drowsiness. While typically non-impairing, driving should be avoided if drowsiness or dizziness occurs. Rest, proper nutrition, and hydration are recommended for optimal recovery. Your doctor may order blood tests and other diagnostics to monitor treatment response.
Primary Ingredients of Seytri T 1000mg/125mg Injection
No text provided. Please provide the text you wish to be rewritten.
Uses of Seytri T 1000mg/125mg Injection
Infections caused by bacteria
Major Benefits of Seytri T 1000mg/125mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of Seytri T 1000mg/125mg Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Seytri T 1000mg/125mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Seytri T 1000mg/125mg Injection works:
Seytri T, a 1000mg/125mg injectable formulation, unites the antibiotic Ceftriaxone with the beta-lactamase inhibitor Tazobactum. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, vital for bacterial viability. Tazobactum's role is to counteract bacterial resistance, thereby bolstering Ceftriaxone's antibacterial efficacy.
SAFETY ADVICE
AlcoholSAFE
Concurrent use of alcohol and Seytri T 1000mg/125mg Injection presents no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Seytri T (1000mg/125mg) is typically deemed safe for use during gestation. Preclinical trials using animal models revealed minimal or no harm to offspring; despite this, data from human trials remain scarce.
Breast feedingCAUTION
Administration of Seytri T 1000mg/125mg Injection to breastfeeding mothers requires careful consideration. Mothers should discontinue breastfeeding throughout the course of treatment and until the medication is fully cleared from their system.
DrivingUNSAFE
Administration of Seytri T 1000mg/125mg Injection could result in reduced awareness, impaired vision, drowsiness, and dizziness. Driving should be avoided if such effects manifest.
KidneyCONSULT YOUR DOCTOR
Data regarding the administration of Seytri T 1000mg/125mg Injection to individuals with renal impairment is scarce. Physician consultation is advised.
LiverCAUTION
The administration of Seytri T 1000mg/125mg Injection requires careful consideration in individuals with advanced hepatic impairment. Dosage modification of Seytri T 1000mg/125mg Injection might be necessary; physician consultation is advised. Altering the Seytri T 1000mg/125mg Injection dosage is not suggested for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Seytri T 1000mg/125mg Injection :
Should you forget a scheduled Seytri T 1000mg/125mg Injection, seek medical advice immediately.
Facts to Know About Seytri T 1000mg/125mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Treatment | Antimicrobial Agents |
